Results 51 to 60 of about 10,033 (195)

Developing juvenile localized scleroderma (jLS) consensus treatment regimens for comparative effectiveness studies [PDF]

open access: yesPediatric Rheumatology Online Journal, 2012
Li Suzanne C   +12 more
doaj   +2 more sources

DNA methylation patterns in juvenile systemic sclerosis and localized scleroderma

open access: greenClinical Immunology, 2021
Scleroderma refers to a group of chronic fibrotic immune-mediated diseases of unknown etiology. Characterizing epigenetic changes in childhood-onset scleroderma, systemic sclerosis or localized scleroderma, has not been previously performed. The aim of this study was to assess DNA methylation differences and similarities between juvenile systemic ...
Patrick Coit   +4 more
openalex   +4 more sources

Neurological and psychological aspects of scleroderma of the face and neck in children

open access: yesЛечащий Врач, 2021
In the structure of morbidity, among rheumatic diseases in children, juvenile scleroderma takes the third place in frequency after juvenile idiopathic arthritis and systemic lupus erythematosus.
M. S. Pavlova   +9 more
doaj   +1 more source

SHARE – workpackage 5: evidence based recommendations for diagnosis and treatment of juvenile localized scleroderma and juvenile systemic sclerosis [PDF]

open access: goldPediatr Rheumatol Online J, 2014
Culpo R   +19 more
europepmc   +3 more sources

Localized scleroderma in children

open access: yesPrzegląd Dermatologiczny, 2020
Localized scleroderma is an autoimmune disease affecting the dermis and underlying tissues (subcutaneous tissue, fascia, muscles, bones). The disease mainly occurs in women aged 20–50 years; however, children aged 7–10 years represent about 15% of all ...
Katarzyna A. Wolska-Gawron   +1 more
doaj   +1 more source

Juvenile Localized Scleroderma: A Very Rare Case

open access: diamondDelta Medical College Journal, 2015
Juvenile localized scleroderma (JLS) is a rare chronic inflammatory and fibrosing disorder. It can result in significant morbidity, disfigurement, and severe functional, aesthetic and psychological disabilities. Patients with JLS should be identified early, evaluated extensively, treated aggressively, and monitored carefully.
Nibedita Paul   +4 more
openalex   +3 more sources

Immunochip analysis identifies multiple susceptibility loci for systemic sclerosis [PDF]

open access: yes, 2014
In this study, 1,833 systemic sclerosis (SSc) cases and 3,466 controls were genotyped with the Immunochip array. Classical alleles, amino acid residues, and SNPs across the human leukocyte antigen (HLA) region were imputed and tested.
  +75 more
core   +1 more source

Recent Advances in Systemic Scleroderma in Childhood [PDF]

open access: yes, 2015
Ann Paediatr Rheumatol Annals of paediatric rheumatolog http://www.aprjournal.org/ 2146-2909 ...
Constantin, Tamás   +4 more
core   +1 more source

Pansclerotic Morphea with Features of Eosinophilic Fasciitis: Distinct Entities or Part of a Continuum? [PDF]

open access: yes, 2014
Scleroderma is a highly complex disorder in its clinical manifestations and pathogenesis. It has a wide range of clinical manifestations due to varying degrees of vasculopathy, autoimmunity, altered endothelium function, and abnormal fibrosis.
Canty, Kristi   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy